|
Post by jmei on Nov 20, 2015 13:15:30 GMT -5
All of Napoli, Uehara, Victorino, Drew and Carp were undoubtedly buy-low acquisitions. They happened to have hit on a bunch in a row and then lost on a bunch in a row.
|
|
|
Post by Chris Hatfield on Nov 20, 2015 13:26:48 GMT -5
They did pretty well on buy-low guys in 2013. I was referring to 2014 & 2015....In 2013, many of those additions were IMO not buy-low, most were solid players, not spectacular, but solid...Nap, Koji, Vic, Drew, Carp even Ross & Dempster. I think what was surprising, was that just about ALL of them had good or great years. Since then--Sizemore, Mujica, Cook, Machi, Masterson, Ogando, Peguero, Weeks, I consider as real buy low candidates & none of them panned out. Burke Badenhop and Tommy Layne are undoubtedly "buy low" guys from the past two years who panned out. They've also continued to reap the rewards of past buy low guys like Holt and Wright. Robbie Ross might count too depending on what you think of Ranaudo. I guess I'd just ask that if you're looking at a two-year window, what you'd think a reasonable percentage of success on "buy low" guys is. Isn't there a reason they're "buy low" guys in the first place? As for the bullpen, it comes down to how much you're willing to spend on that part of the roster. In real money (i.e., not AAV), the Red Sox have $24,650,000 tied up in Kimbrel, Koji, and the projected arb salaries of Tazawa and Ross alone. If Kelly's in your bullpen, add another $3.2M. Looking at 2014, at least, nobody spent more than just over $25M on their bullpen except the Dodgers, who were also spending a great deal more than anyone else. www.fangraphs.com/blogs/2014-payroll-allocation-by-position/ That said, $30M would be right in that 15% sweet spot on a $200M payroll, so one more guy on a $5M/yr deal would be a good fit, but only if he pitches up to that level, and I think gambling on that is something a lot of us would take pause at.
|
|